These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 35695580)

  • 1. Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA Transcription and HBV Replication through Genetic Downregulation of Hepatocyte Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular DNA via Interacting with Promyelocytic Leukemia Protein.
    Li Y; He M; Gong R; Wang Z; Lu L; Peng S; Duan Z; Feng Y; Liu Y; Gao B
    J Virol; 2022 Jul; 96(13):e0054622. PubMed ID: 35695580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon Alpha Induces Multiple Cellular Proteins That Coordinately Suppress Hepadnaviral Covalently Closed Circular DNA Transcription.
    Cheng J; Zhao Q; Zhou Y; Tang L; Sheraz M; Chang J; Guo JT
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLF2 Interacts with the SMC5/6 Complex to Direct Hepatitis B Virus Episomal DNA to Promyelocytic Leukemia Bodies for Transcriptional Repression.
    Yao Q; Peng B; Li C; Li X; Chen M; Zhou Z; Tang D; He J; Wu Y; Sun Y; Li W
    J Virol; 2023 Jul; 97(7):e0032823. PubMed ID: 37338350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA.
    Hofmann S; Plank V; Groitl P; Skvorc N; Hofmann K; Luther J; Ko C; Zimmerman P; Bruss V; Stadler D; Carpentier A; Rezk S; Nassal M; Protzer U; Schreiner S
    Microbiol Spectr; 2023 Jun; 11(3):e0044623. PubMed ID: 37199632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.
    Palumbo GA; Scisciani C; Pediconi N; Lupacchini L; Alfalate D; Guerrieri F; Calvo L; Salerno D; Di Cocco S; Levrero M; Belloni L
    PLoS One; 2015; 10(11):e0142599. PubMed ID: 26580974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
    Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
    Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Sensor Interferon-Inducible Protein 16 Inhibits the Function of Hepatitis B Virus Covalently Closed Circular DNA by Integrating Innate Immune Activation and Epigenetic Suppression.
    Yang Y; Zhao X; Wang Z; Shu W; Li L; Li Y; Guo Z; Gao B; Xiong S
    Hepatology; 2020 Apr; 71(4):1154-1169. PubMed ID: 31402464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide impacts hepatitis B virus core nuclear localization and efficiently interferes with HBV infection.
    Hofmann S; Luther J; Plank V; Oswald A; Mai J; Simons I; Miller J; Falcone V; Hansen-Palmus L; Hengel H; Nassal M; Protzer U; Schreiner S
    Microbiol Spectr; 2024 May; 12(5):e0378823. PubMed ID: 38567974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4α.
    Li L; Li Y; Xiong Z; Shu W; Yang Y; Guo Z; Gao B
    Antiviral Res; 2019 Oct; 170():104568. PubMed ID: 31351930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
    Zhong Y; Wu C; Xu Z; Teng Y; Zhao L; Zhao K; Wang J; Wang W; Zhan Q; Zhu C; Chen X; Liang K; Cheng X; Xia Y
    J Virol; 2022 Nov; 96(21):e0136222. PubMed ID: 36226986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel function of SART1 in HNF4α transcriptional regulation contributes to its antiviral role during HBV infection.
    Teng Y; Xu Z; Zhao K; Zhong Y; Wang J; Zhao L; Zheng Z; Hou W; Zhu C; Chen X; Protzer U; Li Y; Xia Y
    J Hepatol; 2021 Nov; 75(5):1072-1082. PubMed ID: 34242702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases.
    Piracha ZZ; Saeed U; Kim J; Kwon H; Chwae YJ; Lee HW; Lim JH; Park S; Shin HJ; Kim K
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA.
    Zhuang AQ; Chen Y; Chen SM; Liu WC; Li Y; Zhang WJ; Wu YH
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells.
    Peng B; Jing Z; Zhou Z; Sun Y; Guo G; Tan Z; Diao Y; Yao Q; Ping Y; Li X; Ren T; Li B; Li W
    J Virol; 2023 Jan; 97(1):e0171722. PubMed ID: 36475867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases.
    Ren JH; Hu JL; Cheng ST; Yu HB; Wong VKW; Law BYK; Yang YF; Huang Y; Liu Y; Chen WX; Cai XF; Tang H; Hu Y; Zhang WL; Liu X; Long QX; Zhou L; Tao NN; Zhou HZ; Yang QX; Ren F; He L; Gong R; Huang AL; Chen J
    Hepatology; 2018 Oct; 68(4):1260-1276. PubMed ID: 29624717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners.
    Xu L; Wu Z; Tan S; Wang Z; Lin Q; Li X; Song X; Liu Y; Song Y; Zhang J; Peng J; Gao L; Gong Y; Liang X; Zuo X; Ma C
    Antiviral Res; 2018 May; 153():114-123. PubMed ID: 29580980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
    Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
    J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
    Cheng ST; Hu JL; Ren JH; Yu HB; Zhong S; Wai Wong VK; Kwan Law BY; Chen WX; Xu HM; Zhang ZZ; Cai XF; Hu Y; Zhang WL; Long QX; Ren F; Zhou HZ; Huang AL; Chen J
    J Hepatol; 2021 Mar; 74(3):522-534. PubMed ID: 32987030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy.
    Chung YL; Tsai TY
    Mol Cancer Res; 2009 Oct; 7(10):1672-85. PubMed ID: 19808906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional states differ in their vulnerability to damage.
    Wang Y; Li Y; Zai W; Hu K; Zhu Y; Deng Q; Wu M; Li Y; Chen J; Yuan Z
    Hepatology; 2022 May; 75(5):1275-1288. PubMed ID: 34779008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.